Background/AimsAnti-tumor necrosis factor drugs (anti-TNF) and thiopurines are important treatment options in patients with inflammatory bowel disease (IBD), including during pregnancy. However, there are limited data on the benefit/risk profile of anti-TNF and thiopurines during pregnancy in Asia. The aim of this study was to analyze pregnancy outcomes of female Japanese IBD patients treated with anti-TNF and/or thiopurines.MethodsThis cross-sectional study assessed pregnancy outcomes in 72 women with IBD. Pregnancy outcomes were compared among 31 pregnancies without exposure to infliximab (IFX), adalimumab (ADA), or thiopurines; 24 pregnancies with exposure to anti-TNF treatment (23 IFX, 1 ADA); 7 pregnancies with exposure to thiopurines ...
Background: Thiopurines are an effective treatment for moderate to severe inflammatory bowel disease...
BACKGROUND: Women with inflammatory bowel diseases (IBD) often receive biologicals during pregnancy ...
BACKGROUND: Women with inflammatory bowel diseases (IBD) often receive biologicals during pregnancy ...
International audienceBACKGROUND AND AIMS: Few studies have been conducted addressing the safety of ...
Background: Infliximab (IFX) and adalimumab (ADA) are attractive treatment options in patients with ...
Background The safety of anti-tumour necrosis factor (TNF) agents during pregnancy is a major concer...
International audienceBACKGROUND: The safety of anti-tumour necrosis factor (TNF) agents during preg...
Background & aimsPregnant women with inflammatory bowel disease (IBD) may require biologic or th...
Background & Aims Most data on the safety of thiopurine therapy for inflammatory bowel disease (IBD)...
Background and Aims: Inflammatory bowel disease (IBD) commonly affects women during their reproducti...
International audienceOBJECTIVES:Inflammatory bowel diseases (IBD) need long-term treatment, which c...
This systematic review examined on whether there are more adverse pregnancy outcomes among inflammat...
Background/Aims The onset of inflammatory bowel disease (IBD) usually occurs at young age, and there...
This thesis aimed to provide more insight into important clinical topics regarding IBD and reproduct...
Background: Thiopurines are an effective treatment for moderate to severe inflammatory bowel disease...
BACKGROUND: Women with inflammatory bowel diseases (IBD) often receive biologicals during pregnancy ...
BACKGROUND: Women with inflammatory bowel diseases (IBD) often receive biologicals during pregnancy ...
International audienceBACKGROUND AND AIMS: Few studies have been conducted addressing the safety of ...
Background: Infliximab (IFX) and adalimumab (ADA) are attractive treatment options in patients with ...
Background The safety of anti-tumour necrosis factor (TNF) agents during pregnancy is a major concer...
International audienceBACKGROUND: The safety of anti-tumour necrosis factor (TNF) agents during preg...
Background & aimsPregnant women with inflammatory bowel disease (IBD) may require biologic or th...
Background & Aims Most data on the safety of thiopurine therapy for inflammatory bowel disease (IBD)...
Background and Aims: Inflammatory bowel disease (IBD) commonly affects women during their reproducti...
International audienceOBJECTIVES:Inflammatory bowel diseases (IBD) need long-term treatment, which c...
This systematic review examined on whether there are more adverse pregnancy outcomes among inflammat...
Background/Aims The onset of inflammatory bowel disease (IBD) usually occurs at young age, and there...
This thesis aimed to provide more insight into important clinical topics regarding IBD and reproduct...
Background: Thiopurines are an effective treatment for moderate to severe inflammatory bowel disease...
BACKGROUND: Women with inflammatory bowel diseases (IBD) often receive biologicals during pregnancy ...
BACKGROUND: Women with inflammatory bowel diseases (IBD) often receive biologicals during pregnancy ...